Hadeer A. Aglan

608 total citations
32 papers, 407 citations indexed

About

Hadeer A. Aglan is a scholar working on Surgery, Genetics and Molecular Biology. According to data from OpenAlex, Hadeer A. Aglan has authored 32 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 12 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Hadeer A. Aglan's work include Mesenchymal stem cell research (12 papers), Tissue Engineering and Regenerative Medicine (6 papers) and Pancreatic function and diabetes (6 papers). Hadeer A. Aglan is often cited by papers focused on Mesenchymal stem cell research (12 papers), Tissue Engineering and Regenerative Medicine (6 papers) and Pancreatic function and diabetes (6 papers). Hadeer A. Aglan collaborates with scholars based in Egypt, Saudi Arabia and United States. Hadeer A. Aglan's co-authors include Hanaa H. Ahmed, Ahmed E. Abdel Moneim, Sayed A. El‐Toumy, Hanan H. Beherei, Mohamed A. M. Ali, Mostafa Mabrouk, Azza A. Matloub, Ahmed Abdrabou, Mohamed R. Mohamed and Khalda Amr and has published in prestigious journals such as Scientific Reports, Journal of Materials Science Materials in Medicine and Naunyn-Schmiedeberg s Archives of Pharmacology.

In The Last Decade

Hadeer A. Aglan

31 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hadeer A. Aglan Egypt 12 85 64 61 57 51 32 407
Hira Butt Pakistan 10 47 0.6× 45 0.7× 86 1.4× 57 1.0× 46 0.9× 16 326
Danial Khayatan Iran 13 109 1.3× 84 1.3× 31 0.5× 38 0.7× 23 0.5× 29 549
Fereshteh Nejaddehbashi Iran 11 97 1.1× 71 1.1× 108 1.8× 45 0.8× 40 0.8× 40 388
Sami Gharbia Romania 14 92 1.1× 97 1.5× 85 1.4× 45 0.8× 17 0.3× 25 406
Erika Rendra Germany 4 168 2.0× 60 0.9× 34 0.6× 37 0.6× 32 0.6× 5 500
Amal H. Hamza Egypt 10 102 1.2× 44 0.7× 23 0.4× 77 1.4× 27 0.5× 24 372
Huarong Shao China 16 189 2.2× 69 1.1× 115 1.9× 20 0.4× 60 1.2× 36 696
Xiyue Li China 12 133 1.6× 58 0.9× 54 0.9× 145 2.5× 23 0.5× 34 546
Maytham T. Qasim Iraq 14 121 1.4× 64 1.0× 25 0.4× 77 1.4× 21 0.4× 47 626
Yao Qi China 11 338 4.0× 59 0.9× 58 1.0× 40 0.7× 45 0.9× 18 599

Countries citing papers authored by Hadeer A. Aglan

Since Specialization
Citations

This map shows the geographic impact of Hadeer A. Aglan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hadeer A. Aglan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hadeer A. Aglan more than expected).

Fields of papers citing papers by Hadeer A. Aglan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hadeer A. Aglan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hadeer A. Aglan. The network helps show where Hadeer A. Aglan may publish in the future.

Co-authorship network of co-authors of Hadeer A. Aglan

This figure shows the co-authorship network connecting the top 25 collaborators of Hadeer A. Aglan. A scholar is included among the top collaborators of Hadeer A. Aglan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hadeer A. Aglan. Hadeer A. Aglan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aglan, Hadeer A., et al.. (2025). Role of CD133 antibody-conjugated nanocarrier in enhancing the targetability of hepatocellular carcinoma stem cells. Scientific Reports. 15(1). 30441–30441. 2 indexed citations
2.
Ahmed, Hanaa H., et al.. (2025). Preconditioning of bone marrow mesenchymal stem cells with sodium hydrosulfide enhances their therapeutic potential in type II collagen–induced arthritis rat model. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(11). 15645–15663. 1 indexed citations
3.
Ahmed, Hanaa H., et al.. (2025). Sodium alginate-based nanoformulation: optimistic approach for enhancing the anti-obesogenic effect of rutin. Egyptian Pharmaceutical Journal. 24(2). 0–0. 1 indexed citations
4.
Ahmed, Hanaa H., et al.. (2024). Chemical Profile and Potential Application of Agri‐food Waste Products for Counteracting Diabetes Induced Neuropathy in Rats. Chemistry & Biodiversity. 21(12). e202400843–e202400843. 1 indexed citations
5.
Aglan, Hadeer A., et al.. (2024). Generation of cardiomyocytes from stem cells cultured on nanofibrous scaffold: Experimental approach for attenuation of myocardial infarction. Tissue and Cell. 89. 102461–102461. 11 indexed citations
6.
7.
Aglan, Hadeer A., et al.. (2023). Bone marrow stem cell-derived β-cells: New issue for diabetes cell therapy. Tissue and Cell. 86. 102280–102280. 11 indexed citations
8.
Aglan, Hadeer A., et al.. (2022). Adipose Tissue-derived Cardiomyocytes for Enhancing Cardiac Remodeling in a Rat Model of Acute Myocardial Infarction. ROMANIAN BIOTECHNOLOGICAL LETTERS. 27(1/2022). 3315–3329. 1 indexed citations
9.
Mohamed, Mohamed R., et al.. (2021). Nanomaterial-induced mesenchymal stem cell differentiation into osteoblast for counteracting bone resorption in the osteoporotic rats. Tissue and Cell. 73. 101645–101645. 6 indexed citations
10.
11.
Aglan, Hadeer A., et al.. (2020). Modulation of bone turnover aberration: A target for management of primary osteoporosis in experimental rat model. Heliyon. 6(2). e03341–e03341. 13 indexed citations
12.
13.
Mohamed, Mohamed R., et al.. (2020). Osteoblast-Based Therapy—A New Approach for Bone Repair in Osteoporosis: Pre-Clinical Setting. Tissue Engineering and Regenerative Medicine. 17(3). 363–373. 14 indexed citations
14.
Ahmed, Hanaa H., Hadeer A. Aglan, Mostafa Mabrouk, Ahmed Abdrabou, & Hanan H. Beherei. (2019). Enhanced mesenchymal stem cell proliferation through complexation of selenium/titanium nanocomposites. Journal of Materials Science Materials in Medicine. 30(2). 24–24. 34 indexed citations
15.
Aglan, Hadeer A., et al.. (2019). Nanotechnological Applications Hold a Pivotal Position in Boosting Stem Cells Osteogenic Activity: In Vitro and In Vivo Studies. Applied Biochemistry and Biotechnology. 190(2). 551–573. 4 indexed citations
16.
Ahmed, Hanaa H., et al.. (2016). New approaches in the horizon for treatment of Alzhimer’s disease.. Der pharmacia lettre. 8(8). 158–166. 1 indexed citations
17.
Ahmed, Hanaa H., et al.. (2016). Pre-Clinical Study for the Antidiabetic Potential of Selenium Nanoparticles. Biological Trace Element Research. 177(2). 267–280. 58 indexed citations
18.
Salem, Neveen A., Hanaa H. Ahmed, Hadeer A. Aglan, & Shaimaa ElShebiney. (2016). Nanofiber-expanded stem cells mitigate liver fibrosis: Experimental study. Tissue and Cell. 48(5). 544–551. 7 indexed citations
19.
Matloub, Azza A., et al.. (2016). Influence of bioactive sulfated polysaccharide-protein complexes on hepatocarcinogenesis, angiogenesis and immunomodulatory activities. Asian Pacific Journal of Tropical Medicine. 9(12). 1200–1211. 20 indexed citations
20.
Ahmed, Hanaa H., Ahmed M. Salem, Hazem Atta, et al.. (2016). Updates in the pathophysiological mechanisms of Parkinson’s disease: Emerging role of bone marrow mesenchymal stem cells. World Journal of Stem Cells. 8(3). 106–106. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hira Butt Breakdown of academic impact, for papers by Danial Khayatan Breakdown of academic impact, for papers by Fereshteh Nejaddehbashi Breakdown of academic impact, for papers by Sami Gharbia Breakdown of academic impact, for papers by Erika Rendra Breakdown of academic impact, for papers by Amal H. Hamza Breakdown of academic impact, for papers by Huarong Shao Breakdown of academic impact, for papers by Xiyue Li Breakdown of academic impact, for papers by Maytham T. Qasim Breakdown of academic impact, for papers by Yao Qi
Rankless by CCL
2026